Created at	Source	Raw Value	Validated value
Oct. 17, 2022, 10:36 a.m.	usa	Combined variable that includes outcomes 2, 3 and 4 detailed below;Overall survival at 30 days.;Reduction of suspicion of systemic thrombotic symptomatic events;Use of Mechanical ventilation invasive or non invasive including high flow nasal cannula oxigen	Combined variable that includes outcomes 2, 3 and 4 detailed below;Overall survival at 30 days.;Reduction of suspicion of systemic thrombotic symptomatic events;Use of Mechanical ventilation invasive or non invasive including high flow nasal cannula oxigen
Jan. 30, 2021, 12:31 a.m.	usa	Length of hospital stay (days);Length of ICU stay (days);Overall survival at 30 days.;Progression on the WHO Progression Scale during follow-up.;Reduction of suspicion of systemic thrombotic symptomatic events;Use of Mechanical ventilation	Length of hospital stay (days);Length of ICU stay (days);Overall survival at 30 days.;Progression on the WHO Progression Scale during follow-up.;Reduction of suspicion of systemic thrombotic symptomatic events;Use of Mechanical ventilation